| scholarly article | Q13442814 |
| P356 | DOI | 10.1126/SCIENCE.1249361 |
| P698 | PubMed publication ID | 24557836 |
| P50 | author | Merone Roose-Girma | Q87191297 |
| P2093 | author name string | Domagoj Vucic | |
| Vishva M Dixit | |||
| Søren Warming | |||
| Katherine E Wickliffe | |||
| Neeraj Kapoor | |||
| Kim Newton | |||
| M Cristina de Almagro | |||
| Laszlo Komuves | |||
| Dorothy M French | |||
| Joshua Webster | |||
| Ronald E Ferrando | |||
| Debra L Dugger | |||
| P433 | issue | 6177 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | necroptosis | Q3346925 |
| apoptotic process | Q14599311 | ||
| Fas (TNFRSF6)-associated via death domain | Q14907140 | ||
| Caspase 8 | Q14911968 | ||
| Receptor (TNFRSF)-interacting serine-threonine kinase 1 | Q21981433 | ||
| Receptor-interacting serine-threonine kinase 3 | Q21984804 | ||
| P304 | page(s) | 1357-1360 | |
| P577 | publication date | 2014-02-20 | |
| P1433 | published in | Science | Q192864 |
| P1476 | title | Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis | |
| P478 | volume | 343 |
| Q44512805 | 2014: signaling breakthroughs of the year |
| Q33756960 | A Mechanistic Review of Cell Death in Alcohol-Induced Liver Injury |
| Q42555606 | A RIPK3-caspase 8 complex mediates atypical pro-IL-1β processing |
| Q30396736 | A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis. |
| Q38242025 | A long-awaited merger of the pathways mediating host defence and programmed cell death. |
| Q91759768 | A major role for ferroptosis in Mycobacterium tuberculosis-induced cell death and tissue necrosis |
| Q38580336 | A tale of two domains - a structural perspective of the pseudokinase, MLKL. |
| Q52430545 | ASC- and caspase-8-dependent apoptotic pathway diverges from the NLRC4 inflammasome in macrophages. |
| Q40555960 | Absence of RIPK3 predicts necroptosis resistance in malignant melanoma |
| Q37330901 | Activation of necroptosis in human and experimental cholestasis. |
| Q34409204 | Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death |
| Q36162984 | Activity of Uncleaved Caspase-8 Controls Anti-bacterial Immune Defense and TLR-Induced Cytokine Production Independent of Cell Death |
| Q91272588 | Activity of caspase-8 determines plasticity between cell death pathways |
| Q38348935 | Aging and uremia: Is there cellular and molecular crossover? |
| Q30279270 | An Islet-Targeted Genome-Wide Association Scan Identifies Novel Genes Implicated in Cytokine-Mediated Islet Stress in Type 2 Diabetes |
| Q26751108 | An outline of necrosome triggers |
| Q38640411 | Apoptosis Evaluation by Electrochemical Techniques. |
| Q39392301 | Apoptosis and Necroptosis as Host Defense Strategies to Prevent Viral Infection |
| Q91703599 | Apoptosis and necroptosis in the liver: a matter of life and death |
| Q59134753 | Apoptosis of intestinal epithelial cells restricts Clostridium difficile infection in a model of pseudomembranous colitis |
| Q26781665 | Apoptosis, Necrosis, and Necroptosis in the Gut and Intestinal Homeostasis |
| Q83231561 | Autophagy regulates inflammatory programmed cell death via turnover of RHIM-domain proteins |
| Q91739247 | Autophosphorylation at serine 166 regulates RIP kinase 1-mediated cell death and inflammation |
| Q92236020 | Axonal Degeneration Is Mediated by Necroptosis Activation |
| Q58696646 | BRAF and AXL oncogenes drive RIPK3 expression loss in cancer |
| Q40254604 | Bcl-xL mediates RIPK3-dependent necrosis in M. tuberculosis-infected macrophages |
| Q90349450 | Biallelic RIPK1 mutations in humans cause severe immunodeficiency, arthritis, and intestinal inflammation |
| Q37043034 | Border Security: The Role of RIPK3 in Epithelium Homeostasis |
| Q38792072 | CHIP controls necroptosis through ubiquitylation- and lysosome-dependent degradation of RIPK3. |
| Q91698006 | Casein kinase-1γ1 and 3 stimulate tumor necrosis factor-induced necroptosis through RIPK3 |
| Q47114378 | Caspase-1 Engagement and TLR-Induced c-FLIP Expression Suppress ASC/Caspase-8-Dependent Apoptosis by Inflammasome Sensors NLRP1b and NLRC4. |
| Q57099957 | Caspase-8 Collaborates with Caspase-11 to Drive Tissue Damage and Execution of Endotoxic Shock |
| Q35781701 | Caspase-8 scaffolding function and MLKL regulate NLRP3 inflammasome activation downstream of TLR3 |
| Q37625431 | Caspase-8: not so silently deadly |
| Q39277461 | Caspase-8: regulating life and death |
| Q42056483 | Cell biology. RIPK3 takes another deadly turn |
| Q47614555 | Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses. |
| Q97533806 | Cell death in chronic inflammation: breaking the cycle to treat rheumatic disease |
| Q27014671 | Cell death-associated molecular-pattern molecules: inflammatory signaling and control |
| Q36347355 | Cellular IAP proteins and LUBAC differentially regulate necrosome-associated RIP1 ubiquitination |
| Q58545718 | Central role of RIPK1-VDAC1 pathway on cardiac impairment in a non-human primate model of rheumatoid arthritis |
| Q42367954 | Characterization of GSK'963: a structurally distinct, potent and selective inhibitor of RIP1 kinase |
| Q37715361 | Characterization of the Histopathologic Features in Patients in the Early and Late Phases of Cutaneous Leishmaniasis |
| Q57214771 | Circulating RIPK3 levels are associated with mortality and organ failure during critical illness |
| Q91691371 | Circulating cell death biomarker TRAIL is associated with increased organ dysfunction in sepsis |
| Q90069563 | Cleavage of RIPK1 by caspase-8 is crucial for limiting apoptosis and necroptosis |
| Q38530635 | Cloaked in ubiquitin, a killer hides in plain sight: the molecular regulation of RIPK1. |
| Q39010178 | Combination of IAP antagonist and IFNγ activates novel caspase-10- and RIPK1-dependent cell death pathways. |
| Q38636158 | Complete overview of protein-inactivating sequence variations in 36 sequenced mouse inbred strains |
| Q39105381 | Complex Pathologic Roles of RIPK1 and RIPK3: Moving Beyond Necroptosis |
| Q39495482 | Coordinated ubiquitination and phosphorylation of RIP1 regulates necroptotic cell death. |
| Q58758677 | Curcumol induces RIPK1/RIPK3 complex-dependent necroptosis via JNK1/2-ROS signaling in hepatic stellate cells |
| Q40416781 | Cutting Edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient mice. |
| Q27335987 | Cytotoxicity of crystals involves RIPK3-MLKL-mediated necroptosis |
| Q28271163 | DNA damage and the balance between survival and death in cancer biology |
| Q26782124 | Death in the fast lane: what's next for necroptosis? |
| Q92829970 | Dectin-1-induced RIPK1 and RIPK3 activation protects host against Candida albicans infection |
| Q48165246 | Dendritic Cell RIPK1 Maintains Immune Homeostasis by Preventing Inflammation and Autoimmunity |
| Q38801509 | Developmental checkpoints guarded by regulated necrosis |
| Q28240157 | Die another way--non-apoptotic mechanisms of cell death |
| Q37690521 | Distinct Kinase-Independent Role of RIPK3 in CD11c+ Mononuclear Phagocytes in Cytokine-Induced Tissue Repair |
| Q39285713 | Diverse ubiquitin linkages regulate RIP kinases-mediated inflammatory and cell death signaling |
| Q38968529 | Docosahexanoic acid antagonizes TNF-α-induced necroptosis by attenuating oxidative stress, ceramide production, lysosomal dysfunction, and autophagic features |
| Q33755165 | Drug-Induced Liver Injury: Cascade of Events Leading to Cell Death, Apoptosis or Necrosis |
| Q85889775 | Dying autologous cells as instructors of the immune system |
| Q92526760 | Dysregulation of Intestinal Epithelial Cell RIPK Pathways Promotes Chronic Inflammation in the IBD Gut |
| Q90481066 | Effect of Ciprofloxacin on Susceptibility to Aortic Dissection and Rupture in Mice |
| Q92645074 | Effect of the conditional knockout of bone marrow specific RIPK3 gene on bone marrow hematopoiesis in mice |
| Q30408769 | Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. |
| Q39926994 | Expression Profile and Tissue-Specific Distribution of the Receptor-Interacting Protein 3 in BALB/c Mice |
| Q39293707 | Expression of inflammation-related genes in the lung of BALB/c mice response to H7N9 influenza A virus with different pathogenicity |
| Q38365059 | Fate of growth plate hypertrophic chondrocytes: death or lineage extension? |
| Q34044175 | Fight or flight: regulation of emergency hematopoiesis by pyroptosis and necroptosis |
| Q38691490 | Formation and removal of poly-ubiquitin chains in the regulation of tumor necrosis factor-induced gene activation and cell death |
| Q38648036 | Genetic Inhibition of Receptor Interacting Protein Kinase-1 Reduces Cell Death and Improves Functional Outcome After Intracerebral Hemorrhage in Mice |
| Q100385987 | Genetic inactivation of RIP1 kinase does not ameliorate disease in a mouse model of ALS |
| Q92462206 | Genome-wide DNA methylation and RNA expression profiles identified RIPK3 as a differentially methylated gene in Chlamydia pneumoniae infection lung carcinoma patients in China |
| Q34044434 | Glutaminolysis and Transferrin Regulate Ferroptosis |
| Q92531837 | H7N9 influenza A virus activation of necroptosis in human monocytes links innate and adaptive immune responses |
| Q58712149 | HS-1371, a novel kinase inhibitor of RIP3-mediated necroptosis |
| Q100737128 | Hair growth promotion by necrostatin-1s |
| Q41487815 | Herpes simplex virus suppresses necroptosis in human cells |
| Q28386858 | Immunogenic versus tolerogenic phagocytosis during anticancer therapy: mechanisms and clinical translation |
| Q35217897 | Immunohistochemical detection of FLAG-tagged endogenous proteins in knock-in mice |
| Q49679688 | Immunological consequences of kidney cell death |
| Q100395457 | Impaired RIPK1 ubiquitination sensitizes mice to TNF toxicity and inflammatory cell death |
| Q100761744 | Impaired autophagy increases susceptibility to endotoxin-induced chronic pancreatitis |
| Q37109568 | Increased hepatic receptor interacting protein kinase 3 expression due to impaired proteasomal functions contributes to alcohol-induced steatosis and liver injury |
| Q92376977 | Inhibition of RIPK1-dependent regulated acinar cell necrosis provides protection against acute pancreatitis via the RIPK1/NF-κB/AQP8 pathway |
| Q39302537 | Initiation and execution mechanisms of necroptosis: an overview |
| Q99708569 | Integration of innate immune signaling by caspase-8 cleavage of N4BP1 |
| Q91429997 | Interview: a conversation with Vishva M Dixit on his journey from remote African village to apoptosis, necroptosis and the inflammasome |
| Q64096430 | Is autophagy an elective strategy to protect neurons from dysregulated cholesterol metabolism? |
| Q41636978 | K45A mutation of RIPK1 results in poor necroptosis and cytokine signaling in macrophages, which impacts inflammatory responses in vivo. |
| Q36134231 | KLHDC10 Deficiency Protects Mice against TNFα-Induced Systemic Inflammation |
| Q58107473 | Kinase domain dimerization drives RIPK3-dependent necroptosis |
| Q100737257 | Kinase inhibition in autoimmunity and inflammation |
| Q42371937 | Knockdown of RIPK1 Markedly Exacerbates Murine Immune-Mediated Liver Injury through Massive Apoptosis of Hepatocytes, Independent of Necroptosis and Inhibition of NF-κB. |
| Q49636303 | Life and Death of Activated T Cells: How Are They Different from Naïve T Cells? |
| Q38492529 | Live to die another way: modes of programmed cell death and the signals emanating from dying cells |
| Q64296021 | Loading necrostatin-1 composite bone cement inhibits necroptosis of bone tissue in rabbit |
| Q50493756 | MLKL and FADD Are Critical for Suppressing Progressive Lymphoproliferative Disease and Activating the NLRP3 Inflammasome. |
| Q90709088 | MLKL-dependent signaling regulates autophagic flux in a murine model of non-alcoholic fatty liver disease |
| Q38398301 | Manipulation of apoptosis and necroptosis signaling by herpesviruses |
| Q39038663 | Mechanisms of RIPK3-induced inflammation |
| Q38235124 | Mitochondria-mediated apoptosis in mammals |
| Q26745680 | Molecular crosstalk between apoptosis, necroptosis, and survival signaling |
| Q47843948 | Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. |
| Q38250196 | Molecular regulation of cell fate in cerebral ischemia: role of the inflammasome and connected pathways |
| Q40292668 | Mouse cytomegalovirus M36 and M45 death suppressors cooperate to prevent inflammation resulting from antiviral programmed cell death pathways |
| Q91892511 | Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory disease |
| Q38929374 | Myeloid-derived suppressor activity is mediated by monocytic lineages maintained by continuous inhibition of extrinsic and intrinsic death pathways. |
| Q98665172 | Myofiber necroptosis promotes muscle stem cell proliferation via releasing Tenascin-C during regeneration |
| Q37165646 | N-end rule pathway inhibition assists colon tumor regression via necroptosis |
| Q42369047 | NEMO regulates a cell death switch in TNF signaling by inhibiting recruitment of RIPK3 to the cell death-inducing complex II. |
| Q37269029 | NF-κB functions as a molecular link between tumor cells and Th1/Tc1 T cells in the tumor microenvironment to exert radiation-mediated tumor suppression |
| Q64814767 | Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases |
| Q38319916 | Necroptosis and its role in inflammation |
| Q26764791 | Necroptosis in acute kidney injury: a shedding light |
| Q52663210 | Necroptosis in cardiovascular disease - a new therapeutic target. |
| Q54981573 | Necroptosis in development and diseases. |
| Q39044997 | Necroptosis in development, inflammation and disease. |
| Q39404657 | Necroptosis in neurodegenerative diseases: a potential therapeutic target |
| Q91345013 | Necroptosis is dispensable for motor neuron degeneration in a mouse model of ALS |
| Q102369408 | Necroptosis is dispensable for the development of inflammation-associated or sporadic colon cancer in mice |
| Q92318936 | Necroptosis of Intestinal Epithelial Cells Induces Type 3 Innate Lymphoid Cell-Dependent Lethal Ileitis |
| Q59134951 | Necroptosis of infiltrated macrophages drives Yersinia pestis dispersal within buboes |
| Q38799149 | Necroptosis-independent signaling by the RIP kinases in inflammation |
| Q39679537 | Necroptosis: Fifty shades of RIPKs |
| Q40411907 | Necroptosis: Mechanisms and Relevance to Disease |
| Q28087723 | Necroptosis: The Trojan horse in cell autonomous antiviral host defense |
| Q92482642 | Necroptosis: a crucial pathogenic mediator of human disease |
| Q38619561 | Necroptosis: a potential, promising target and switch in acute pancreatitis |
| Q55507699 | Necroptosis: a regulated inflammatory mode of cell death. |
| Q42840026 | Necroptosis: is there a role for mitochondria? |
| Q26778547 | Necroptotic Cell Death Signaling and Execution Pathway: Lessons from Knockout Mice |
| Q34339233 | Necroptotic signaling in adaptive and innate immunity |
| Q38799137 | Necrosome core machinery: MLKL. |
| Q28080158 | Non-Canonical Cell Death Induced by p53 |
| Q39171961 | Non-kinase targets of protein kinase inhibitors |
| Q30352395 | Noncanocial cell death program independent of caspase activation cascade and necroptotic modules is elicited by loss of TGFβ-activated kinase 1. |
| Q52717424 | Novel Protective Role of Nicotinamide Phosphoribosyltransferase in Acetaminophen-Induced Acute Liver Injury in Mice. |
| Q90390254 | Nrf2 deficiency aggravates PM2.5-induced cardiomyopathy by enhancing oxidative stress, fibrosis and inflammation via RIPK3-regulated mitochondrial disorder |
| Q57148426 | Nuclear RIPK3 and MLKL contribute to cytosolic necrosome formation and necroptosis |
| Q58215556 | OTULIN limits cell death and inflammation by deubiquitinating LUBAC |
| Q57821479 | Overexpression of Chicken IRF7 Increased Viral Replication and Programmed Cell Death to the Avian Influenza Virus Infection Through TGF-Beta/FoxO Signaling Axis in DF-1 |
| Q91935996 | PEAK3/C19orf35 pseudokinase, a new NFK3 kinase family member, inhibits CrkII through dimerization |
| Q57158814 | Paving the way for precision medicine v2.0 in intensive care by profiling necroinflammation in biofluids |
| Q38829463 | Post-translational control of RIPK3 and MLKL mediated necroptotic cell death |
| Q28645752 | Ppm1b negatively regulates necroptosis through dephosphorylating Rip3 |
| Q104064750 | Primidone blocks RIPK1-driven cell death and inflammation |
| Q39110327 | Programmed cell death as a defence against infection |
| Q38261258 | Programmed necrosis and necroptosis signalling |
| Q34520528 | Programmed necrosis in inflammation: Toward identification of the effector molecules |
| Q27026709 | Programmed necrosis in the cross talk of cell death and inflammation |
| Q92237404 | Prospects for pharmacological targeting of pseudokinases |
| Q57809696 | Pyroptosis versus necroptosis: similarities, differences, and crosstalk |
| Q49571560 | RGMb protects against acute kidney injury by inhibiting tubular cell necroptosis via an MLKL-dependent mechanism |
| Q52718845 | RIP kinase 1-dependent endothelial necroptosis underlies systemic inflammatory response syndrome. |
| Q91069815 | RIP kinases as modulators of inflammation and immunity |
| Q34924104 | RIP kinases: key decision makers in cell death and innate immunity |
| Q37642622 | RIP1 autophosphorylation is promoted by mitochondrial ROS and is essential for RIP3 recruitment into necrosome |
| Q92126037 | RIP1 inhibition blocks inflammatory diseases but not tumor growth or metastases |
| Q33694708 | RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition |
| Q38940334 | RIP1-dependent Bid cleavage mediates TNFα-induced but Caspase-3-independent cell death in L929 fibroblastoma cells |
| Q90045843 | RIP1/RIP3/MLKL mediates dopaminergic neuron necroptosis in a mouse model of Parkinson disease |
| Q48168744 | RIP3 deficiency exacerbates inflammation in dextran sodium sulfate-induced ulcerative colitis mice model |
| Q42379853 | RIP3 induces apoptosis independent of pronecrotic kinase activity |
| Q35679558 | RIP3 is downregulated in human myeloid leukemia cells and modulates apoptosis and caspase-mediated p65/RelA cleavage |
| Q90672269 | RIPK1 Mediates TNF-Induced Intestinal Crypt Apoptosis During Chronic NF-κB Activation |
| Q38999544 | RIPK1 and PGAM5 Control Leishmania Replication through Distinct Mechanisms. |
| Q33798944 | RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3 |
| Q38987871 | RIPK1 both positively and negatively regulates RIPK3 oligomerization and necroptosis. |
| Q38959073 | RIPK1 can function as an inhibitor rather than an initiator of RIPK3-dependent necroptosis |
| Q49048892 | RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosis. |
| Q40486619 | RIPK1 inhibits ZBP1-driven necroptosis during development |
| Q58700548 | RIPK1 is a critical modulator of both tonic and TLR-responsive inflammatory and cell death pathways in human macrophage differentiation |
| Q47806841 | RIPK1 mediates a disease-associated microglial response in Alzheimer's disease |
| Q38987874 | RIPK1- and RIPK3-induced cell death mode is determined by target availability |
| Q40074113 | RIPK1-dependent apoptosis bypasses pathogen blockade of innate signaling to promote immune defense. |
| Q49025576 | RIPK1-dependent cell death: a novel target of the Aurora kinase inhibitor Tozasertib (VX-680). |
| Q38984566 | RIPK1/RIPK3 promotes vascular permeability to allow tumor cell extravasation independent of its necroptotic function. |
| Q38763365 | RIPK3 Activates Parallel Pathways of MLKL-Driven Necroptosis and FADD-Mediated Apoptosis to Protect against Influenza A Virus. |
| Q37353986 | RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury |
| Q39277433 | RIPK3 in cell death and inflammation: the good, the bad, and the ugly. |
| Q93140480 | RIPK3 mediates renal tubular epithelial cell apoptosis in endotoxin‑induced acute kidney injury |
| Q30623992 | RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL |
| Q54976858 | RIPK3 promotes sepsis-induced acute kidney injury via mitochondrial dysfunction. |
| Q52355659 | RIPK3-deficient mice were not protected from nephrotoxic nephritis. |
| Q96954768 | RIPK3: A New Player in Renal Fibrosis |
| Q64886183 | RNA-Seq-Based Gene Expression Pattern and Morphological Alterations in Chick Thymus during Postnatal Development. |
| Q35801564 | Receptor-Interacting Protein Kinase 3 Deficiency Delays Cutaneous Wound Healing |
| Q34485020 | Receptor-interacting protein kinase 3 deficiency inhibits immune cell infiltration and attenuates organ injury in sepsis |
| Q34568839 | Regulated cell death in AKI. |
| Q38699324 | Regulated necrosis: disease relevance and therapeutic opportunities |
| Q39124019 | Regulation and functions of NLRP3 inflammasome during influenza virus infection |
| Q36674720 | Regulation of RIPK3- and RHIM-dependent Necroptosis by the Proteasome |
| Q55355554 | Regulation of alveolar macrophage death in acute lung inflammation. |
| Q38619242 | Regulation of antiapoptotic and cytoprotective pathways in colonic epithelial cells in ulcerative colitis |
| Q49717299 | Repurposing anticancer drugs for targeting necroptosis |
| Q35369847 | Role of RIP1 in physiological enterocyte turnover in mouse small intestine via nonapoptotic death |
| Q27023218 | Role of necroptosis in the pathogenesis of solid organ injury |
| Q39041502 | Roles of Caspases in Necrotic Cell Death. |
| Q58763483 | SARS-Coronavirus Open Reading Frame-3a drives multimodal necrotic cell death |
| Q42111132 | Sensitizing acute myeloid leukemia cells to induced differentiation by inhibiting the RIP1/RIP3 pathway |
| Q39383323 | Small molecule probes for cellular death machines |
| Q40153668 | Sorafenib tosylate inhibits directly necrosome complex formation and protects in mouse models of inflammation and tissue injury. |
| Q49951925 | Stressed-out ROS take a silent death route |
| Q36446161 | Structural Basis for the Non-catalytic Functions of Protein Kinases. |
| Q51812613 | Surface immobilization of a protease through an inhibitor-derived affinity ligand: a bioactive surface with defensive properties against an inhibitor. |
| Q64262212 | Survival of Single Positive Thymocytes Depends upon Developmental Control of RIPK1 Kinase Signaling by the IKK Complex Independent of NF-κB |
| Q34413437 | TAK1 control of cell death |
| Q26776492 | TNF biology, pathogenic mechanisms and emerging therapeutic strategies |
| Q90196931 | TNFR2 induced priming of the inflammasome leads to a RIPK1-dependent cell death in the absence of XIAP |
| Q43170389 | TRAF2 is a biologically important necroptosis suppressor |
| Q34003273 | Tamoxifen toxicity in cultured retinal pigment epithelial cells is mediated by concurrent regulated cell death mechanisms |
| Q97526637 | The Balance of TNF Mediated Pathways Regulates Inflammatory Cell Death Signaling in Healthy and Diseased Tissues |
| Q39077160 | The Inflammatory Signal Adaptor RIPK3: Functions Beyond Necroptosis |
| Q90061761 | The Molecular Links between Cell Death and Inflammasome |
| Q33434632 | The Pseudokinase MLKL and the Kinase RIPK3 Have Distinct Roles in Autoimmune Disease Caused by Loss of Death-Receptor-Induced Apoptosis |
| Q52689573 | The Receptor Interacting Protein Kinases in the Liver. |
| Q90401064 | The Role of Necroptosis in Cardiovascular Disease |
| Q36968948 | The Tumor Suppressor Hace1 Is a Critical Regulator of TNFR1-Mediated Cell Fate |
| Q62819580 | The anticonvulsive Phenhydan® suppresses extrinsic cell death |
| Q38255302 | The cell death response to enteropathogenic Escherichia coli infection |
| Q26782229 | The cybernetics of TNF: Old views and newer ones |
| Q38530866 | The diverse role of RIP kinases in necroptosis and inflammation |
| Q38809791 | The in vivo evidence for regulated necrosis |
| Q28274739 | The intersection of cell death and inflammasome activation |
| Q91241929 | The many faces of tumor necrosis factor signaling in the intestinal epithelium |
| Q92861156 | The molecular machinery of regulated cell death |
| Q27313354 | The necroptosis-inducing kinase RIPK3 dampens adipose tissue inflammation and glucose intolerance |
| Q49463915 | The p55TNFR-IKK2-Ripk3 axis orchestrates arthritis by regulating death and inflammatory pathways in synovial fibroblasts |
| Q62820026 | The pseudokinase MLKL activates PAD4-dependent NET formation in necroptotic neutrophils |
| Q64234468 | The pseudokinase MLKL regulates hepatic insulin sensitivity independently of inflammation |
| Q28083902 | The role of necroptosis in neurosurgical diseases |
| Q39346095 | The small molecule that packs a punch: ubiquitin-mediated regulation of RIPK1/FADD/caspase-8 complexes |
| Q26853682 | The two faces of receptor interacting protein kinase-1 |
| Q36799655 | Therapeutic hypothermia attenuates tissue damage and cytokine expression after traumatic brain injury by inhibiting necroptosis in the rat. |
| Q34541689 | Triggering necroptosis in cisplatin and IAP antagonist-resistant ovarian carcinoma. |
| Q89865303 | Tristetraprolin regulates necroptosis during tonic Toll-like receptor 4 (TLR4) signaling in murine macrophages |
| Q37412541 | Tubular epithelial cells in renal clear cell carcinoma express high RIPK1/3 and show increased susceptibility to TNF receptor 1-induced necroptosis |
| Q90100566 | Ubiquitination of RIPK1 suppresses programmed cell death by regulating RIPK1 kinase activation during embryogenesis |
| Q38721821 | Viral RNA at Two Stages of Reovirus Infection Is Required for the Induction of Necroptosis. |
| Q37461770 | ZBP1/DAI is an innate sensor of influenza virus triggering the NLRP3 inflammasome and programmed cell death pathways |
| Q50239267 | Zirconium-metalloporphyrin frameworks as a three-in-one platform possessing oxygen nanocage, electron media, and bonding site for electrochemiluminescence protein kinase activity assay |
Search more.